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Abstract: The family Hantaviridae mostly comprises rodent-borne segmented negative-sense RNA 
viruses, many of which are capable of causing devastating disease in humans. In contrast, hantavirus 
infection of rodent hosts results in a persistent and inapparent infection through their ability to evade 
immune detection and inhibit apoptosis. In this study, we used Tula hantavirus (TULV) to investigate 
the interplay between viral and host apoptotic responses during early, peak and persistent phases of 
virus infection in cell culture. Examination of early-phase TULV infection revealed that infected cells 
were refractory to apoptosis, as evidenced by the complete lack of cleaved caspase-3 (casp-3C) 
staining, whereas in non-infected bystander cells casp-3C was highly abundant. Interestingly, at later 
time points, casp-3C was abundant in infected cells, but the cells remained viable and able to continue 
shedding infectious virus, and together these observations were suggestive of a TULV-associated 
apoptotic block. To investigate this block, we viewed TULV-infected cells using laser scanning confocal 
and wide-field deconvolution microscopy, which revealed that TULV nucleocapsid protein (NP) 
colocalized with, and sequestered, casp-3C within cytoplasmic ultrastructures. Consistent with casp-
3C colocalization, we showed for the first time that TULV NP was cleaved in cells and that TULV NP 
and casp-3C could be co-immunoprecipitated, suggesting that this interaction was stable and thus 
unlikely to be solely confined to NP binding as a substrate to the casp-3C active site. To account for 
these findings, we propose a novel mechanism by which TULV NP inhibits apoptosis by spatially 
sequestering casp-3C from its downstream apoptotic targets within the cytosol. 
Introduction: The genus Orthohantavirus within the family Hantaviridae comprises many zoonotic 
segmented negative-sense RNA viruses that are capable of causing devastating human disease, often 
with fatal outcomes. Orthohantaviruses are broadly spherical enveloped viruses, which possess a 
tripartite genome made up of small (S), medium (M) and large (L) RNA segments that minimally 
encode the nucleocapsid protein (NP), glycoprotein precursor (GPC) and RNA-dependent RNA 
polymerase (RdRp), respectively [1, 2]. Many members of the family also encode a small non-
structural protein (NSs) that is accessed from an alternative open reading frame (ORF) and acts as an 
antagonist of the innate immune response [3–5].  
Orthohantaviruses can be divided into New World (NW) and Old World (OW) clades based on their 
country of isolation, with OW viruses being widespread throughout Asia and Europe, and NW viruses 
being found in the Americas [6]. Orthohantaviruses are typically associated with a specific rodent host, 
although recent evidence suggests that bats, shrews, moles and ray-finned fish also act as reservoirs 
[7, 8]. Orthohantaviruses have been shown to cause persistent, often apathogenic infections in these 
hosts, although there is some evidence to suggest that infection is associated with reduced host 
survival [9–13], with histological examination of the lungs, heart and livers of infected animals showing 
some signs of pathology [14].  
Orthohantaviruses are transmitted to humans by the inhalation of aerosolized excreta and other body 
fluids from the infected animal host, although direct human-to-human transmission has also been 
reported for Andes virus (ANDV) [15]. Several human pathologies have been observed for different 
orthohantavirus species, with the disease outcome correlating closely with the two orthohantavirus 
clades; OW orthohantaviruses are associated with haemorrhagic fever with renal syndrome (HFRS), 
whilst NW orthohantaviruses are the causative agent of hantavirus cardiopulmonary syndrome 
(HCPS). While these syndromes afflict different primary organs, both are characterized by excessive 
vascular leakage leading to shock, with human mortality rates ranging from 0.1–10 % for HFRS and up 
to 40 % for HCPS [16, 17]. Endothelial cells are the primary sites of hantavirus multiplication, although 
these cells do not display overt cytopathic effects [18]. This outcome is recapitulated in cell culture 
systems in which orthohantavirus infections are not associated with excessive cytopathology or cell 
lysis, and instead infections can become persistent with ongoing virus shedding for up to 139 days 
post-infection in the case of Seoul virus (SEOV) [19–21]. The ability of hantaviruses to persist suggests 
that they are able to evade pathogen surveillance, and avoid innate immune defence mechanisms 
such as apoptosis. 
Apoptosis is an important component of cellular homeostasis. There are many apoptotic pathways, 
including the caspase cascade, in which a series of cysteine–aspartate proteases are activated by 
cleavage [22]. Viruses have developed complex mechanisms to modulate apoptotic signalling 
pathways to benefit their own survival, which can result in either delay or acceleration of apoptosis 
with pro-viral outcomes. 
There is considerable evidence to suggest that hantaviruses prevent the induction of apoptosis, which 
is consistent with their ability to establish persistence. Puumala virus (PUUV) NP has been shown to 
interact with the Fas-mediated apoptosis enhancer Daxx [23], whilst NP from Hantaan virus (HTNV) 
modulates apoptosis by down-regulating p53 [24]. Furthermore, a panel of six hantaviruses spanning 
three distinct serogroups [ANDV, Dobrava virus (DOBV), HTNV, PUUV, SEOV and Tula virus (TULV)] 
were each recently shown to suppress apoptosis in staurosporine-treated cells. The same study 
suggested that NP plays a direct role in modulating apoptosis through the demonstration that NP can 
be cleaved by purified caspase-3. In addition, recombinant N protein from ANDV, DOBV and PUUV 
have been shown to inhibit both caspase-3 and granzyme B in cell-free assays [25, 26]. 
To better characterize the role of the hantavirus NP in modulating apoptosis, we used the model OW 
orthohantavirus TULV to examine how NP interacts with key components of the apoptotic machinery 
through an extended time course spanning early infection, peak infection and a persistently infected 
state. We demonstrate that TULV infection can persist for over 30 days in mammalian cells, with little 
or no apoptosis induction despite abundant levels of cleaved caspase-3 (casp-3C). We further show 
that TULV NP forms both punctate and tubular ultrastructures within intermediate and persistently 
infected cells, in which active casp-3C is physically sequestered as a consequence of a robust and 
stable association with NP, leading to NP cleavage. We thus propose a model in which the ability of 
TULV to suppress apoptosis is driven by interactions between NP and casp-3C, leading to NP cleavage 
and spatial separation of the executioner caspase from its downstream effectors.  
 
Results 
Generation of tools to quantify TULV components and infectivity:  To characterize the progression of 
TULV infection in cells throughout an extended time course, we first developed tools to accurately 
quantify both TULV components and infectivity. For TULV protein detection, we generated NP 
antisera, and based on phylogenetic analysis of OW clade hantavirus NP amino acid sequences, we 
selected the SEOV NP to raise polyclonal antisera that would be broadly cross-reactive to multiple 
hantavirus NPs, including TULV. The SEOV NP core (residues 111–399; NPcore) was bacterially 
expressed and purified (Fig. 2a, left panel) and used for antibody production. The resulting antisera 
showed cross-reactivity against recombinant SEOV NPcore expressed in bacteria by Western blot 
analysis (Fig. 2a, right panel) and against TULV NP generated in TULV-infected cells at 6 days p.i., as 
assessed by both Western blotting (Fig. 2b) and immunofluorescence (Fig. 2c). These results confirmed 
the high specificity of the antisera, as evidenced by absent background or non-specific staining in 
mock-infected cells. In agreement with previous studies, TULV NP was detected in perinuclear 
ultrastructures and cytoplasmic puncta [20]. Alongside the production of NP antisera, we also 
established a rapid PCR-based assay for the quantitative detection of TULV vRNA replication products, 
calibrated using a standard curve generated using in vitro-transcribed TULV S segment vRNA at a range 
of concentrations. The purity of the vRNA was verified using electrophoresis (Fig. 2d) and Rsq values 
≥0.99 (Fig. 2e). Finally, we developed assays to measure TULV infection kinetics and virus production. 
Conventional infectivity assays that are reliant on plaque formation are problematical due to the low 
cytopathology of hantaviruses, with hantavirus infectivity often being measured by neutral red 
uptake, which is both time-consuming and inaccurate, taking 10 days to produce poorly visible plaques 
(Fig. 1a). To remedy this, we developed an immunofluorescence (IF)-based assay that relies on TULV 
NP antisera for the detection of infected cells (Fig. 1b). This method was used to examine the 
infectivity of a TULV dilution series and the infected cell numbers followed a linear curve with a Rsq 
values ≥0.99 (Fig. 1c). 
Quantification of TULV components and infectivity across a 30-day time course:  We next examined 
TULV multiplication and infectious particle production in Vero E6 cells over an extended time course. 
Cells were infected at an m.o.i. of 0.1, after which supernatants and cell lysates were collected at 
regular time points up to 10 days p.i., with infections carried out at both 32 and 37 °C. Additional 
samples from cultures incubated at 37 °C were also taken at 15, 20, 25 and 30 days p.i. NP antisera 
was used to measure NP accumulation in cell lysates harvested from 37 °C cultures by Western 
blotting, which served as a marker for viral gene expression and virus growth. Amplification of 
intracellular NP was first detected at 1 day p.i. (Fig. 3a; 24 h p.i.), indicating a significant lag prior to 
the onset of detectable gene expression, and also reflecting the low m.o.i. used. Following this, NP 
abundance increased until 3 days p.i. (Fig. 3a; 72 h p.i.), at which time NP abundance reached a plateau 
that did not decline up to 10 days p.i. (Fig. 3a; 240 h p.i.). NP abundance relative to GAPDH was 
calculated using densitometry and represented graphically alongside (Fig. 3a). 
Concomitantly, we used qRT-PCR to quantify the abundance of viral S segment RNAs, harvested as 
virion-associated RNA within released virus particles in the supernatant. This revealed a complex 
pattern that comprised an initial lag phase up to 30 h p.i., where viral RNA levels showed no increase 
over input, indicating an initial lag in genome production and virus release. This was subsequently 
followed by an exponential phase of rapid genome production, and a plateau in RNA detection that 
extended to 10 days p.i. This pattern of RNA detection was observed in TULV grown at both 32 and 37 
°C (Fig. 3b) and was consistent with the profile of NP detection shown above (Fig. 3a). At later time 
points (15–30 days p.i.) genome abundance did not increase further and gradually declined until the 
final 30 days p.i. measurement, although the vRNA abundance remained at least 1 log higher than the 
initial input (Fig. 3c). 
To confirm that the detected RNA levels were due to the release of infectious virus particles, and not 
the release of defective or fragmented RNAs, we also measured TULV infectivity in the supernatants 
(Fig. 3d , e). The overall pattern of infectivity closely followed that of genome RNA abundance, with 
the release of infectious virus remaining at a consistent level until the harvest at 30 days p.i., a 
hallmark of a persistent infection. Based on these observations, we defined 1.5, 7 and 30 days p.i. as 
the time points representing distinct early, peak and persistent phases of virus multiplication, 
respectively. 
In fact, analysis of TULV-infected cultures using NP antisera at 1.5, 7 and 30 days p.i. time points 
correlated with the above metrics (Fig. 3f). At 1.5 days p.i., NP staining was punctate and perinuclear, 
whereas at 7 and 30 days p.i., the staining pattern changed noticeably, with NP forming tubular 
ultrastructures in addition to distinct puncta. There was little evidence of nuclear fragmentation in 
infected cells at any of these time points, which was suggestive of a lack of virus-induced apoptosis, 
although multinucleate syncytia were observed in the 30 days p.i. cultures. 
TULV infection interferes with apoptotic induction in Vero E6 cells: The results thus far showed that 
cultures of TULV-infected Vero E6 cells can be maintained for up to 30 days p.i. without major 
cytopathic effects. This suggests that TULV infection does not readily lead to cell death, correlating 
with previous work that demonstrated the ability of hantaviruses to subvert apoptotic induction. To 
further examine the apoptotic response of Vero E6 cells to TULV infection, infected cell lysates were 
collected every 24 h up to 10 days p.i., and again at 30 days p.i., and the levels of total caspase-3, 
cleaved caspase-3 (casp-3C) and cleaved poly (ADP-ribose) polymerase (PARP-C) were assessed (Fig. 
4).  
Total caspase-3 was detected in TULV-infected cells, with its abundance increasing at later time points 
due to cell proliferation, which is consistent with the increasing abundance of the GAPDH loading 
control. The activated derivative casp-3C, which is indicative of apoptosis induction, was detected in 
TULV cell lysates from 5 to 6 days p.i., with its abundance increasing up to 10 and 30 days p.i. However, 
whilst this was suggestive of TULV-induced apoptosis in infected cell cultures, a lack of PARP-C was 
evident at 6–10 days p.i., and only moderate PARP-C cleavage was observed at 30 days p.i. 
Furthermore, the high levels of casp-3C at 30 days p.i. were inconsistent with the apparent health of 
cells in these persistent cultures (Fig. 3f). Taken together, these findings suggest that although the 
executioner casp-3C was present in its active form, it failed to trigger cell death in TULV-infected cells, 
possibly due to the activity of a TULV component. 
TULV induces apoptosis in bystander cells: The results thus far suggested that the downstream activity 
of executioner casp-3C may be suppressed in TULV-infected cells. We therefore investigated the 
intracellular location of casp-3C in relation to TULV NP in individual cells, first at at 1.5 days p.i., which 
is representative of the early stages of infection.  
At 1.5 days p.i., ~10 % of cells were infected, as evidenced by characteristic punctate TULV NP staining, 
with the numbers of infected cells correlating with the initial m.o.i. of 0.1 (Fig. 5a). In TULV-infected 
cells, NP staining was abundant, whilst minimal casp-3C was detected. Interestingly, casp-3C was 
abundant in uninfected bystander cells (four examples are shown in Fig. 5b), with casp-3C staining in 
a punctate distribution that extended throughout the cytoplasm, suggesting apoptotic induction, 
possibly through receiving indirect pathogen recognition signals from adjacent TULV-infected cells. 
We propose that the likely fate of these cells is death. Casp-3C staining was detected in over 60 % of 
bystander cells, but only in 4 % of TULV-infected cells (Fig. 5c). Fluorescent line scan analysis (Fig. 5b, 
right panel) quantified the expression of casp-3C in one such bystander cell, and revealed clear 
segregation from the TULV N stain in an adjacent infected cell (Fig. 5d). These data suggest that during 
the early stages of virus infection, TULV is not a potent inducer of apoptosis, most likely because of 
the ability of a TULV component to suppress apoptotic stimuli. 
TULV NP sequesters casp-3C at later stages of infection: At 7 days p.i., the majority of cells were 
infected by TULV, as evidenced by the accumulation of NP, which exhibited both punctate staining 
and the formation of large tubular perinuclear structures (Fig. 3f and (Fig. 6a). These TULV infected 
cells exhibited casp-3C staining, but it was noticeable that the levels of staining in relation to that 
exhibited within non-infected bystander cells was low, consistent with the suppression of apoptosis 
by a TULV component. Interestingly, quantification of TULV NP and casp-3C staining by fluorescent 
line scan analysis revealed several instances of colocalization between the two markers within both 
characteristic puncta and larger tubular structures (Fig. 6a, zoomed merge panel and associated line 
scan, left), although in other areas, the two signals were separate. 
Examination of TULV persistently infected cultures at 30 days p.i. revealed all cells to be TULV-infected, 
and exhibiting characteristic TULV NP staining within both discrete puncta and larger tubular 
structures. As at 7 days p.i. (Fig. 6a), casp-3C was detected in these TULV-infected cells and fluorescent 
line scan analysis (Fig. 6b, zoomed merge panel and associated line scan, left) revealed the 
colocalization of casp-3C with NP in both punctate and large tubular structures. 
At these peak and persistent time points (7 and 30 days p.i.), when casp-3C was detected in TULV-
infected cells, a distinct lack of apoptosis within the cells was evident, with most cells apparently 
healthy and able to sustain virus production (Fig. 3e). These observations were difficult to reconcile 
with the abundance of casp-3C observed in these cells, other than through a scenario in which active 
casp-3C was prevented from cleaving downstream substrates in the caspase cascade, possibly through 
its interaction with TULV NP. 
Examination of TULV NP and casp-3C colocalization using wide-field deconvolution microscopy 
(WFDM): To further examine the colocalization of TULV NP and casp-3C in persistently infected cells 
at 30 days p.i., infected cells were assessed by WFDM to enhance the detection sensitivity. As with 
confocal microscopy (Fig. 6), WFDM revealed that TULV-infected cells exhibited casp-3C staining 
within discrete cytoplasmic puncta (Fig. 7a). While some areas of casp-3C staining were distinct from 
TULV NP, a high level of colocalization was observed, with the casp-3C staining appearing to be 
contained within that of TULV NP. Analysis of the spatial distribution of the two proteins using multiple 
fluorescent line scan analyses (Fig. 7b, line scans below) confirmed and quantified the TULV NP and 
casp-3C colocalized signals, consistent with a scenario in which TULV NP compartmentalizes casp-3C. 
Quantification of TULV NP/ casp-3C puncta abundance across early, peak and persistent TULV cultures 
revealed an increased number of colocalized puncta through progression of the 30-day time course, 
with nearly 30 % colocalization of the two proteins at 30 days p.i. (Fig. 7b, histogram). In other areas 
of persistently infected cells, NP and casp-3C staining remained separate, and were quantified using 
multiple line scans (Fig. 7c), with the quantitation of colocalization in early, peak and persistent TULV 
cultures being represented as a histogram. 
TULV NP is cleaved in infected cells and associates robustly with casp-3C: For the orthohantavirus 
members ANDV, DOBV and PUUV, recombinant casp-3C has been shown to mediate cleavage of their 
respective purified NPs in cell-free assays [26]. In the case of ANDV, casp-3C cleaves ANDV NP at the 
sequence DLID285, which conforms to the consensus DXXD motif for caspase-3 cleavage and 
generates a major NP fragment with a molecular mass of approximately 35 kDa. With this knowledge, 
combined with our observation that casp-3C and NP colocalize in TULV-infected cells, we next 
explored the possibility that TULV-NP acted as a cleavage substrate in infected cells. 
Analysis of the TULV NP sequence revealed the presence of an identical DLID motif that is found in the 
ANDV NP, which was previously shown to be recognized and cleaved by casp-3C in cell-free assays. 
Interestingly, whilst the DLID motif was present in NPs from ANDV and TULV, it was absent in HTNV, 
PHV and SEOV (Fig. 8a). Cleavage of the TULV NP at this site was predicted to generate TULV NP 
fragments of ~32 and ~16 kDa. To test whether cleavage at this site occurs during infection, we 
examined TULV-infected cell lysates for NP-derived cleavage products by Western blotting using anti-
NP antisera, which revealed the abundant presence of NP cleavage products precisely matching these 
predicted masses (NP 32 and NP 16 kDa, respectively; Fig. 8b). The 16 kDa NP fragment was detected 
with high abundance at 3 days p.i., which coincided with the initial detection of full-length NP, 
suggesting that NP cleavage occurs early during TULV infection. The fact that TULV NP possesses the 
same casp-3C target motif as ANDV, along with the consistent colocalization of TULV NP and casp-3C 
shown above, strongly implicates casp-3C as being responsible for the TULV NP cleavage we observed. 
To further examine the TULV NP and casp-3C interaction, we next performed co-immunoprecipitation 
analysis using TULV NP antisera to pull down TULV NP and its interacting partners from 30 days p.i. 
TULV-infected cells. Subsequent Western blot analysis of eluted fractions revealed the presence of 
full-length NP, as well as cleaved NP 32 and NP 16 kDa forms, along with abundant casp-3C (Fig. 8c). 
These data are entirely consistent with the co-localization studies described above (Fig. 7b) and show 
that the TULV NP and casp-3C interaction is highly stable. The ability of NP to pull down casp-3C with 
such abundance argues for a scenario in which the interaction involves residues that are not confined 
to the casp-3C active site, which alone would be expected to result in an extremely transient enzyme 
: substrate interaction that would not be amenable to immunoprecipitation. 
Taken together, we demonstrate for the first time that a hantaviral NP interacts with casp-3C in 
infected cells in a robust and stable manner, and we suggest that the nature of this interaction results 
in physical sequestration of casp-3C within NP compartments, and drives the suppression of the 
apoptotic response. 
Discussion: Here, we investigated the interplay between TULV and apoptosis induction in Vero E6 cells 
throughout an extended time course, spanning early, peak and persistent phases of infection. Previous 
work [23, 25, 26, 29] has shown that TULV and other hantaviruses inhibit apoptosis, and two 
observations made in our current study lend support to this proposal. First, while casp-3C was 
undetectable in TULV-infected cells at 1.5 days p.i., in the same cultures, casp-3C was highly abundant 
in non-infected bystander cells, consistent with the ability of a TULV component to block apoptotic 
induction. Second, we showed that TULV can form persistently infected cultures up to 30 days p.i. 
without significant levels of cytopathic effects or the development of an apoptotic phenotype, despite 
casp-3C being highly abundant. 
Our finding that TULV hinders apoptotic induction is in agreement with published work, but is in 
conflict with some previous studies in which TULV infection was associated with abundant detection 
of apoptotic markers by Western blotting [30–32]. However, we propose that this discrepancy may 
have arisen through technical differences in the approaches used to detect apoptotic markers. Here, 
we examined the spatial distribution of both NP and apoptotic markers in individual cells, rather than 
culture lysates that comprise both infected and uninfected cells. Whilst fluorescent imaging resulted 
in the abundant detection of casp-3C at early time points following infection, it was predominantly 
located in bystander cells, rather than in TULV-infected cells. Thus, we propose that apoptosis of 
bystander cells, rather than TULV-infected cells, may be the source of the apoptotic markers observed 
in previous studies. Bystander effects have been described previously in SEOV, HTNV, ANDV [31] and 
HIV, where the Env glycoprotein induces apoptotic induction in neighbouring cells [33], and have been 
utilized in cancer therapy by employing ‘suicide genes’ that allow the production of a toxic metabolite 
that acts deleteriously on neighbouring cells [34]. 
Previous work has shown that a variety of hantaviral NPs, either expressed recombinantly or purified 
from virions, can be cleaved in cell-free assays by recombinant activated caspase-3. Here, we show 
that TULV NP is cleaved during infection (Fig. 8a), with the apparent mass of released fragments being 
consistent with caspase-3 cleavage at a conserved DLID sequence, identical to that recently identified 
as a caspase-3 cleavage site for ANDV NP [26]. The role of TULV NP cleavage in these infected cells 
remains undetermined. One possibility is that it acts as a ‘decoy’ substrate, as was reported for Junín 
arenavirus (JUNV) [35], in which the JUNV NP delays the onset of apoptosis by acting as a ‘caspase 
sink’, diverting caspase-3 from the cleavage of downstream effectors. An equivalent scenario for TULV 
NP is entirely consistent with our findings that TULV NP associates with casp-3C and is cleaved, as well 
as the established ability of TULV to delay the apoptotic response. 
However, we suggest that NP might delay or hinder the apoptotic response using a different 
mechanism. The ability of NP to interact with casp-3C, as determined by both indirect 
immunofluorescent imaging and immunoprecipitation analysis, reveals a highly robust interaction. 
Interestingly, line scans (Fig. 7b) revealed that the TULV NP and casp-3C colocalizing signals did not 
occupy precisely the same positions, rather NP appeared to form a distinct boundary around casp-3C, 
suggestive of a virus-induced compartment in which casp-3C was physically separated from the 
cytosolic environment. The demonstration that casp-3C and NP could be immunoprecipitated by NP 
antisera is perhaps not surprising given the extensive immunofluorescent colocalization described 
above, but it reveals a robust and stable casp-3C/NP interaction, and one that differs from a canonical 
enzyme : substrate interaction that involves binding at the active site alone. The apparent stability of 
the TULV NP and casp-3C interaction, as demonstrated by their co-immunoprecipitation, argues that 
the interaction likely encompasses additional residues outside of the active site, and that the 
association of these two components is not transient. 
Based on this evidence, we propose a model in which TULV NP compartmentalizes casp-3C and 
physically separates it from downstream components of the caspase apoptotic cascasde. This 
mechanism of apoptosis protection has previously been demonstrated in other types of human 
disease. In Alzheimer’s disease, amyloid-β (Aβ) fibrils sequester caspase-3 into compartments to 
protect cells from apoptosis [36]. Heat shock protein 27 (Hsp27) also sequesters procaspase- 3 and 
cytochrome-c, which prevents the formation of the apoptosome during thermotolerance [37]. In 
addition, the ced-9 molecule, a Bcl-2 homologue that is found in Caenorhabditis elegans, is a well-
established example of a protein that regulates apoptosis by sequestering the caspase activating 
factor ced-4, an analogue of mammalian Apaf-1, to the mitochondria, preventing non-programmed 
apoptosis. When the interaction between ced-9 and ced-4 is disrupted, downstream caspase cleavage 
and subsequent activation result in apoptosis [38–40]. These examples provide precedents for 
apoptotic protein sequestration acting to prevent apoptosis in both health and disease systems. 
In summary, the colocalization and co-precipitation of TULV NP and casp-3C, paired with the presence 
of a casp-3C recognition site, provides evidence that NP is involved in interference with the host cell 
apoptotic pathway. We therefore suggest that TULV NP interferes with apoptosis by binding to and 
sequestering active caspase-3 in NP-coated compartments, preventing casp-3C from activating its 
downstream substrates. 
Fig. 1. TULV immunofluorescent infectivity assay. (a) An example of a neutral red plaque assay well 
at 10−3 dilution displaying typical indistinct hantavirus plaques. (b) Example images of TULV-infected 
or mock-infected wells used for the immunofluorescent infectivity assay using anti-NP antisera and 
the Incucyte ZOOM instrument, with (IF) and without (object mask) analysis using masking software 
to count immunofluorescent units. (c) Linear range describing the dilution factor of the 
immunofluorescent assay. 
Fig. 2. Identification and quantification of TULV components. (a) Bacterially expressed and purified 
recombinant SEOV NPcore used for antigen production migrated with an apparent molecular weight 
of ~30 kDa following SDS-PAGE, as visualized by Coomassie staining. The SEOV NPcore was detected 
by Western blotting using NPcore antisera. (b) Cross-reactivity of the SEOV NPcore antisera against 
TULV NP (~50 kDa) expressed in infected Vero E6 cell lysates, shown by Western blotting. Cell lysates 
were collected at 120 h p.i. and GAPDH was used as a loading control. (c) Indirect immunofluorescence 
images of TULV-infected and mock-infected Vero E6 cells using the NP antisera, taken on a Zeiss 
LSM880 confocal microscope using 40× magnification, with the white bar representing 20 μM. Nuclei 
are shown in blue and TULV NP is shown in green. (d) In vitro-transcribed TULV S segment vRNA, 
serially diluted to form a calibration curve for quantitative RT-PCR. (e) Example calibration curve 
generated experimentally by quantitative RT-PCR. 
Fig. 3. Kinetics of TULV replication in Vero E6 cells. (a) Western blot using anti-TULV NP and anti-
GAPDH antibodies of TULV-infected Vero E6 cell lysates collected at time points spanning 1–10 days 
p.i., with NP levels quantified using densitometry in relation to the GAPDH loading control. (b) TULV 
RNA genome copies ml−1 as quantified using one-step quantitative RT-PCR on samples collected 1–
10 days p.i., and (c) extended to 1–30 days p.i. (d) TULV infectious titres determined by the 
immunofluorescence infectivity assay on samples collected 1–10 days p.i., and e) extended to 1–30 
days p.i. (f) Laser scanning confocal images taken of TULV-infected Vero E6 cells at 1.5 days p.i., 7 days 
p.i. and 30 days p.i. using 40× magnification and stained using anti-TULV NP antisera, with the white 
bar representing 20 μM. Nuclei were stained with DAPI and are shown in blue and TULV NP is shown 
in green. 
Fig. 4. Examination of the induction of apoptotic markers during TULV infection of Vero E6 cells. 
TULV-infected Vero E6 cell lysates collected from 1 to 10 days p.i. and 30 days p.i. and examined by 
Western blotting for the presence of TULV NP, pre-caspase-3 (casp-3), active caspase-3 (casp-3C) and 
cleaved PARP (PARP-C), alongside a GAPDH loading control. 
Fig. 5. Detection of active cleaved caspase-3 in bystander cells, but not infected cells, within TULV-
infected Vero E6 cultures. (a) Indirect immunofluorescence of TULV-infected Vero E6 cells at 1.5 days 
p.i. using antisera specific for TULV NP and cleaved caspase-3 (casp-3C). The images were taken using 
laser scanning confocal microscopy with 40× magnification, with casp-3C shown in red, TULV NP 
shown in green and DAPI shown in blue. The white bar represents 20 μM. (b) Merged zoom images of 
four representative bystander cells with the white bar representing 10 μM. (c). Quantification of the 
percentage of TULV-infected and bystander cells exhibiting casp-3C staining. (d). Fluorescent line 
scans of both bystander and TULV-infected cells of the right-hand merge panel shown in panel (a), 
taken along the grey bars using Fiji software, with the red line representing NP and the green line 
representing casp-3C . 
Fig. 6. Active caspase-3 colocalizes with TULV NP in the cytoplasm at later stages of infection. (a) 
Indirect immunofluorescence of Vero E6 cells infected with TULV at 7 days p.i. or (b) 30 days p.i. 
Images were taken using laser scanning confocal microscopy using 100× magnification, with casp-3C 
signal in red, nucleocapsid protein (NP) in green and DAPI in blue, with the white bar representing 20 
μM. Merged images are shown on the right, with a zoomed merge in which the white bar represents 
10 μM. A fluorescent line scan was taken along the grey bar shown on the zoomed merged image 




Cell culture: TULV Moravia strain 5302 v/95 and Vero E6 cells were kindly provided by Dr Roger 
Hewson, Public Health England, UK. Virus propagation was carried out in Vero E6 cells grown in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10 % foetal bovine serum (FBS) 
(Sigma Aldrich), 100 U ml−1 penicillin and 100 μg ml−1 streptomycin at 37 °C in a 5 % CO2 atmosphere. 
TULV stocks were confirmed as mycoplasma-free using MycoAlert (Lonza). 
 Nucleocapsid protein production and purification: A cDNA representing the NP ORF from SEOV strain 
Humber (accession number JX879769.1), optimized for bacterial expression, was generated 
synthetically (GeneArt, Thermo Fisher Scientific) and inserted into the pMK-RQ vector. This was 
subsequently used as the template for amplification of the NP ‘core’, comprising residues E111–G399 
(NPcore), using the primer set 5′- TGTTGGATCCGAACCGACAGGTCAGACCGCAGATTG-3′ and 5′- GGTG 
CTCG AGTTAACC CAGG TGAA AGTT ATCCACG GC-3′. The amplified core region was then cloned into 
the pET28a (+) expression vector behind sequences for both the 6xHis affinity tag and the SUMO tag 
for overexpression in Escherichia coli BL21 DE3 Gold cells. Bacterial cultures were induced using 0.5 
mM IPTG and then incubated overnight at 18 °C in a 180 r.p.m. shaking incubator. Bacterial pellets 
were collected by centrifugation at 4000 g for 20 min at 4 °C before resuspension in ice-cold lysis 
buffer [500 mM NaCl, 20 mM Tris-HCl pH 8, 20 mM MgCl2, 5 mM β-mercaptoethanol, 1 % Triton X-
100, 1 mg ml−1 lysozyme (Sigma Aldrich), 1 pellet EDTA-free protease inhibitors (Roche), 1 U RNase, 
1 U DNase) and sonicated. The insoluble fraction was pelleted by centrifugation at 20 000 g for 1 h at 
4 °C and soluble protein was collected in the supernatant. The soluble fraction was then applied to a 
5 ml HisTrap (GE Healthcare) column and washed with 5 column volumes of 25–100 mM imidazole 
wash buffers (500 mM NaCl, 20 mM Tris, 5 mM β-Me). Recombinant NPcore was eluted from the 
column using 10 column volumes of elution buffer (500 mM imidazole, 500 mM NaCl, 20 mM Tris, 5 
mM β-mercaptoethanol). The 6xHis SUMO tag was removed by incubation with 1 U ml−1 Ulp1 
protease overnight at 4 °C. The cleaved protein was diluted 1 : 10 in 20 mM elution buffer before being 
passed over a 5 ml HisTrap column to remove tag and protease. The collected flow-through was 
concentrated in a 10 kDa molecular weight cut-off concentrator (Amicon) to 0.5 mg ml−1. The purity 
(>85 %) of the resulting NPcore was determined by densitometry following SDS-PAGE and Coomassie 
staining.  
Antibodies: TULV NP antibody was generated in sheep with 4×200 mg inoculations of recombinant 
purified NPcore (Alta Biosciences). Serum was collected pre-inoculation and post-one, -two, -three 
and -four inoculations. The serum was centrifuged at 4000 g for 20 min at 4 °C to remove debris before 
being stored at −20 °C. Polyclonal antibodies against cleaved caspase-3, caspase-3 and cleaved PARP 
were purchased from New England Biolabs and monoclonal antibodies against GAPDH were 
purchased from GeneTex.  
Quantitative reverse transcriptase-PCR: Quantitative RT-PCR was carried out as previously described 
[27] with adaptations to the GoTaq 1-Step RT-qPCR system protocol (Promega). TULV S segment RNA 
was isolated from infected cell culture medium using a viral RNA mini kit (Qiagen) and reverse-
transcribed using the primers 5′- GCCT CTAG AATG AGCC AACT CAAA GAAA TACAAGAGG-3′ and 5′- 
GCCC TCGA GTTA GATT TTTA GCGGTTCC TGGTTTG-3′. The S segment ORF was sub-cloned into 
pCDNA3.1 (+) T7 expression vector and used as template for transcription S segment RNA using the 
mMESSAGE mMACHINE T7 Transcription kit (Thermo Fisher Scientific) and purified using the RNeasy 
mini kit (Qiagen). RNA purity was assessed using electrophoresis examination (Fig. 1a) and the 
concentration was adjusted to 108, 106, 104 and 102 genomic copies per quantitative RT-PCR (qRT-
PCR) reaction (5 μl). Genomic copies of experimental samples were determined from the generated 
standard curve. 
Virus infections: Vero E6 cells were seeded out at a density of 1×105 cells per well for a 12-well plate 
or 1×106 cells per 25 cm2 flask. TULV was adsorbed to monolayers at a multiplicity of infection (m.o.i.) 
of 1–0.1 in DMEM for 90 min before DMEM supplemented with 2 % FBS, 100 U ml−1 penicillin and 
100 μg ml−1 streptomycin (2 % DMEM) was added. Persistent TULV infections were carried out in 25 
cm2 flasks and infected cells were seeded onto coverslips 24 h before fixation. Cells were fixed in 4 % 
paraformaldehyde at 36 h post-infection (p.i.), 7 days p.i. and 30 days p.i. to demonstrate early, peak 
and persistent infections. 
TULV time course: Vero E6 cells were seeded out at a density of 6×105 cells per well of a six-well plate 
and infected with TULV at an m.o.i. of 0.1. At each time point, cells were scraped into the cell culture 
medium and stored at −80 °C. Cell cultures were clarified by centrifugation at 20 000 g for 10 min at 4 
°C. RNA extractions were carried out on clarified cell culture supernatant using a viral RNA mini kit 
(Qiagen) and RNA was quantified in duplicate using one-step qRT-PCR. Infectious TULV was titrated in 
triplicate using an immunofluorescence assay. 
Virus titration: Vero E6 cells were seeded out at a density of 5×103 cells per well of a 96-well plate or 
at 6×105 cells per well of a 6-well plate and incubated at 37 °C in a 5 % CO2 incubator overnight. TULV 
was diluted 10−1 to 10−5 at a 1 : 10 dilution in DMEM. Diluted virus was adsorbed to cell monolayers 
alongside neat TULV in volumes of 100 μl (96-well) and 200 μl (6-well). TULV was adsorbed for 90 min 
at 37 °C on a rocking platform. Following adsorption, 100 μl 2 % FBS DMEM was added to 96-well plate 
cells and incubated at 37 °C for 72 h in a 5 % CO2 incubator. For six-well plates, inoculum was removed 
and overlaid with 3 ml 2 % agarose diluted 1 : 1 in 2 % FBS DMEM and this was added to each well and 
incubated at 37 °C for 7 days in a 5 % CO2 incubator. A second overlay of 2 ml 2 % agarose diluted 1 : 
1 in 2 % FBS DMEM was added containing 45.3 μg ml−1 neutral red (Sigma Aldrich) before incubation 
at 37 °C in a 5 % CO2 incubator for a further 3 days. Plaques were considered to be areas with reduced 
staining and these were counted [28]. Ninety-six-well plate cells were fixed in icecold methanol and 
infected cells were identified through indirect staining using the anti-NPcore antibody in conjunction 
with an Alexa Fluor 488 secondary antibody (Thermo Fisher Scientific). The Incucyte Zoom instrument 
(Essen Bioscience) using a 10× objective lens was used to image infected monolayers. The Incucyte 
ZOOM software was used to calculate the number of infected cells per well by extrapolating an 
average a value from three fluorescent images of each well. Infectivity was quantified as 
immunofluorescent units per ml (IU ml−1), which represented the number of resulting infectious foci 
per ml of inoculum. Each sample was quantified in triplicate. 
Indirect immunofluorescence: Infected monolayers on coverslips were permeabilized in ice-cold 
methanol and incubated at −20 °C for at least 1 h before being washed in 1× PBS and blocked in 5 % 
BSA in 1× PBS (produced in-house). Primary antibody staining was carried out in 1 % BSA in 1× PBS 
using sheep anti-NPcore at 1 : 2000 dilution and rabbit anti-cleaved caspase-3 (casp-3C) antibody at 1 
: 200 dilution. Incubations were carried out for 2 h at room temperature, followed by thorough 
washing in 1× PBS. Secondary antibody staining was carried out using donkey anti-sheep Alexa Fluor 
488 and donkey anti-rabbit Alexa Fluor 647 at a 1 : 1000 dilution for 1 h. DAPI staining was carried out 
by incubation with 300 mM DAPI for 5 min at room temperature. Coverslips were mounted onto slides 
using VECTASHIELD Antifade Mounting Medium (Vector Laboratories) and sealed using clear nail 
polish. Infected cells were imaged using the Zeiss LSM880 upright confocal microscope at 40× 
magnification (Carl Zeiss Ltd) and the DeltaVision Widefield Deconvolution microscope at 100× 
magnification (GE Healthcare). 
Western blotting: TULV infections, as described above, were carried out on Vero E6 monolayers in six-
well plates. At 24, 48, 72, 96, 120, 144, 168, 192, 216 and 240 h p.i. cells were scraped into cell culture 
medium and collected by centrifugation at 20 000 g for 10 min at 4 °C before resuspension in 50 μl 
PBS. An equal volume of NuPage loading buffer (Thermo Fisher Scientific) was added and samples 
were heated at 95 °C for 5 min. Protein samples were separated by 15 % SDS-PAGE and then 
transferred to an Immobilon-FL polyvinylidene difluoride (PVDF) membrane (Merck Millipore), which 
was probed with sheep anti-NPcore, rabbit anti-cleaved caspase-3 (casp-3C), caspase-3 (casp-3) and 
cleaved PARP (PARP-C). Mouse anti-GAPDH antibody was used as a loading control. Protein was 
detected using IRDye 800CW donkey anti-goat IgG (H+L), IRDye 800CW donkey anti-rabbit IgG (H+L) 
and IRDye 680RD donkey anti-mouse IgG (H+L), and visualized by the Odyssey Imaging system (LI-
COR). Densitometry was carried out using Fiji software. 
Co-immunoprecipitation: Three 175 cm3 flasks of Vero E6 cells at 60 % confluence were infected with 
TULV at an m.o.i. of 0.1, as previously described. At 30 days p.i. cells were scraped into the cell culture 
medium and centrifuged at 4000 g for 10 min at 4 °C. The supernatant was discarded and the cell 
pellet was washed in 1× PBS, followed by resuspension in ice-cold lysis buffer [150 mM NaCl, 50 mM 
TrisHCl (pH 8.0), 1 % NP-40 alternative, 0.1 % sodium dodecyl sulphate, 1× EDTA-free protease 
inhibitor tablets (Roche)], and incubated on ice for 30 min before being clarified by centrifugation at 
1000 g for 10 min. Clarified lysate was used for TULV NP immunoprecipitation with anti-NPcore using 
the Dynabeads protein G immunoprecipitation kit (Thermo Fisher Scientific) following the 
manufacturer’s instructions. Then 1× NuPAGE loading dye was added directly to the beads and the 
samples were heated at 95 °C for 5 min. The samples were centrifuged at 10 000 g to pellet the beads 
and supernantant was added to SDS-PAGE gels. Mock samples were treated similarly to infected 
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